Post Reply
321-340 of 1106
Manulife US Real Estate Mgt Pte. Ltd. has started taking orders from retail investors for its US$ 470 million initial public offering in Singapore, which is slated to be the country' s biggest equity fundraising in nearly two years.
The company, is listing some of its U.S. assets through a real-estate investment trust, will sell its units@US$0.83, It' s offering it IPO prospectus on Thursday, @top end of the pr range.
The deal could improve sentiment toward the IPO market in Southeast Asia, which has been hit by a lack of investor demand for new offerings. Investors have, as the weak global economy has hit the commodity-dependent region particularly hard. So far this year, companies in Southeast Asia have raised US$505 million through new listings, compared with US$2.6 billion a year ago, according to Dealogic data.
Manulife US REIT said in its prospectus it will sell 566 million units, of which 169.54 million are being taken up by certain select investors.
Manulife US REIT has secured six cornerstone investors, including sovereign-wealth fund Oman Investment Fund , M' sian asset-management Co - Fortress Capital Asset Management and DBS Bank Ltd. private-banking clients. Cornerstone investors generally buy shares ahead of the IPO, helping bankers and company to mkt the deal better to other institutional and retail investors.
Institutional investors have taken up 350.78 million units, while the retail tranche is expected to sell 45.79 million units. It aims to start trading on S' pore Exchange on May 20.
It 2nd time the company, a unit of Canadian insurer Manulife Financial Corp., is tapping the Singapore IPO market, after failing to launch an offering for the REIT last year because of weak market conditions and reduced investor appetite.
Offering would provide rare exposure to U.S. property mkt. Prospectus said the REIT would initially have three office properties in the U.S.
The company is seeking to offer a yield of 6.6% for this year and 7.1% in 2017, higher than the 6.3% yield it was offering last year for 2016.
Singapore is home to about 39 real-estate investment trusts with a combined market capitalization of nearly US$49 billion. Investors are drawn to their yields, which far exceed the 0.25% offered on 12-month Singapore-dollar deposits.
Credit Suisse AG, DBS Bank and Deutsche Bank are among the lenders advising Manulife US REIT on the IPO.
Dow Jones Newswire
Read more: http://www.nasdaq.com/article/manulife-us-reit-prices-singapore-ipo-at-top-end-of-range-20160512-00015#ixzz48VM8YRMS
how many shares avail for the public retail tranche to press?!
Manulife US REIT IPO Summary
http://mystocksinvesting.com/singapore-stocks/manulife-us-reit/manulife-us-reit-ipo-prospectus-and-fundamental-analysis/
This may bring some cheers roe Reits counters.
teeth53 ( Date: 03-May-2016 15:55) Posted:
|
Manulife US Reit delayed its IPO last year July because of volatile mkt conditions.
Manulife US Reit. This time round will sell about 35% worth up to U.S.$470m, offering of share to institutional, to cornerstone investors, including private banking clients of Credit Suisse Group and DBS Group Holdings, according to the people.
DBS Bank, Malaysia's Fortress Capital Asset Management, Oman Investment Fund and Lucille Holdings Pte are cornerstone investors in the offering, the people said.
Commitments from cornerstone investors and indicated interest from anchor investors accounts for about 80% of the sale, according to the people.
Manulife US Reit plans to start trading on May 20, the people said.
DBS, China Int'l Capital Corp, Credit Suisse and Deutsche Bank AG are arranging the sale.
Manulife US Reit. This time round will sell about 35% worth up to U.S.$470m, offering of share to institutional, to cornerstone investors, including private banking clients of Credit Suisse Group and DBS Group Holdings, according to the people.
DBS Bank, Malaysia's Fortress Capital Asset Management, Oman Investment Fund and Lucille Holdings Pte are cornerstone investors in the offering, the people said.
Commitments from cornerstone investors and indicated interest from anchor investors accounts for about 80% of the sale, according to the people.
Manulife US Reit plans to start trading on May 20, the people said.
DBS, China Int'l Capital Corp, Credit Suisse and Deutsche Bank AG are arranging the sale.
Acromec Limited trade in Catalist under the stock code ?43F?.
Acromec is a Singapore-based company that specialises in the design and construction of facilities requiring controlled environments, such as laboratories, medical and sterile facilities and cleanrooms. The company primarily serves the healthcare, biomedical, research and academia, and electronics sectors, and counts Singapore General Hospital, Agency for Science, Technology and Research (A*STAR), National University of Singapore, Procter & Gamble and Johnson Matthey Singapore, amongst its clients.
Lim Say Chin, Executive Chairman and Managing Director of Acromec, said: ?With two decades of experience in the provision of integrated specialist engineering solutions within controlled environments.
Mohamed Nasser Ismail, Head of Equity Capital Market (SME) and Head of Capital Market Development, SGX, said.
The listing of Acromec brings the total number of companies on Catalist to 178, with a combined market capitalisation of S$9 billion.
Acromec opened at $0.25 today. Currently trading at $0.28 cents.
Acromec is a Singapore-based company that specialises in the design and construction of facilities requiring controlled environments, such as laboratories, medical and sterile facilities and cleanrooms. The company primarily serves the healthcare, biomedical, research and academia, and electronics sectors, and counts Singapore General Hospital, Agency for Science, Technology and Research (A*STAR), National University of Singapore, Procter & Gamble and Johnson Matthey Singapore, amongst its clients.
Lim Say Chin, Executive Chairman and Managing Director of Acromec, said: ?With two decades of experience in the provision of integrated specialist engineering solutions within controlled environments.
Mohamed Nasser Ismail, Head of Equity Capital Market (SME) and Head of Capital Market Development, SGX, said.
The listing of Acromec brings the total number of companies on Catalist to 178, with a combined market capitalisation of S$9 billion.
Acromec opened at $0.25 today. Currently trading at $0.28 cents.
teeth53 ( Date: 07-Apr-2016 07:12) Posted:
|
Engineering firm Acromec to raise $4.5m in Catalist IPO
http://www.straitstimes.com/business/companies-markets/engineering-firm-acromec-to-raise-45m-in-catalist-ipo
The offer comprises 27 million new shares at 22 cents each, including 1.5 million public offer shares, 22.5 million placement shares and three million reserved shares.
the company designs and builds engineering solutions for controlled environments such as research labs and medical operating theatres. These projects comprise about 70% of its orders. The rest is mainly work for the electronics sector.
Notable projects include designing and building Class 1 clean room, S' pore' s highest standard for clean rooms, for the Agency for Science, Technology and Research (A*Star) in Fusionopolis Two. It has also designed and built operating theatres for Singapore General Hospital.
The company has projects for several upcoming hospitals, including the Admiral Medical Centre.
It is also looking to bring its expertise in designing operating theatres to countries like Myanmar, where demand for healthcare is growing.
The company is in robust financial health and is debt-free, with $11 million in cash.
Its main competitors are multinationals from Japan and Europe but Mr Lim cites his firm' s ability to build a sniff sensory lab for Procter and Gamble which can purge smells in 30 minutes, more than two hours faster than labs its competitors have built.
Public offer closes at noon on April 14, with trading of the shares begins on April 18.
Home-grown engineering services provider Acromec lodged a preliminary offer document to prepares for a listing on the Singapore Exchange' s Catalist board.
The firm, set up in 1996, specialises in designing and building facilities that require controlled environments, such as cleanrooms and laboratories as well as medical and sterile facilities.
It services mainly the healthcare, biomedical, research and academia, and electronics sectors, counting Singapore General Hospital, A*Star, National University of Singapore, Procter & Gamble and Johnson Matthey among its key customers.
Acromec raked in a net profit of $3.4 mil last year, 22.1% higher than the $2.8 mil in 2014, as revenue surged 53.1% to $35.4 mil thanks to several key projects.
They include the design, supply and installation of laboratory furniture at the Innovis and Kinesis buildings in Fusionopolis, which contributed $7.3 mil to the company' s top line, and the fitting-out of new operating theatres and supporting areas at the National Heart Centre, which added $6.5 mil.
" The healthcare sector here will continue to provide us with very good growth potential," said Mr Lim, noting that the Govt has plans to make significant investments in expanding all aspects of the healthcare system. A significant portion of the proceeds will go towards beefing up the company' s working capital so it can undertake more projects, especially those of a larger scale.
http://www.straitstimes.com/business/companies-markets/acromec-gears-up-to-list-on-catalist-board
Anchor Resources Opene' - 0.18 cents n closed at 0.146 cents. Volume changed hands - 55,194,200 mil shr. It hit a high of 0.199 cents n a low of 0.144 cents.
Buy vol - 114,200, 0.146c verse 0.148c. Sell vol - 16,400.
Buy vol - 114,200, 0.146c verse 0.148c. Sell vol - 16,400.
edwinjup ( Date: 17-Mar-2016 07:16) Posted:
|
http://www.sharejunction.com/sharejunction/insightArticle.htm?id=0
TOP GLOVE: World?s largest glovemaker to list on SGX - Maybank Kim Eng analyst: John Cheong, CFA
Listing could bring excitement to Singapore SGX
Top Glove, world's largest glovemaker by production volume and 2nd by mkt cap, is planning a secondary listing in Singapore, boosting trading liquidity.
It intends to explore with its substantial shareholder the sale of about SGD20m worth of shares on the SGX.
No new shares will be issued. The exercise is expected to complete by 3Q16.
M'sia glove analyst - think this move will hardly help to boost liquidity for Top Glove in KLSE. IHH is a good case in point, its trading vol has remained low in Singapore, since its dual listing in 2012.
"With Top Glove's secondary listing, we could see more news and perhaps more glovemakers listing on SGX. It makes sense since the glovemakers export globally and Singapore fits in as a widely recognised financial hub and politically stable nation.
We maintain a BUY calls - on Riverstone and UG Healthcare with TPs of SGD1.18 and SGD0.52." - John Cheong
The beneficiaries will be the investment bankers and perhaps the substantial shareholder that will be selling its stake.
Positive for SGX-listed glovemakers.
This could pan out well for the Singapore-listed glovemakers, as they are trading at a notable discount of around 25% in terms of forward P/E vs the Malaysia-listed ones, due to lack of understanding, having only a small cluster of glove stocks listed here and less news flow.
Malaysia has 7 listed glove stocks vs 2 in Singapore.
Full report here. Courtesy from NextInsight
TOP GLOVE: World?s largest glovemaker to list on SGX - Maybank Kim Eng analyst: John Cheong, CFA
Listing could bring excitement to Singapore SGX
Top Glove, world's largest glovemaker by production volume and 2nd by mkt cap, is planning a secondary listing in Singapore, boosting trading liquidity.
It intends to explore with its substantial shareholder the sale of about SGD20m worth of shares on the SGX.
No new shares will be issued. The exercise is expected to complete by 3Q16.
M'sia glove analyst - think this move will hardly help to boost liquidity for Top Glove in KLSE. IHH is a good case in point, its trading vol has remained low in Singapore, since its dual listing in 2012.
"With Top Glove's secondary listing, we could see more news and perhaps more glovemakers listing on SGX. It makes sense since the glovemakers export globally and Singapore fits in as a widely recognised financial hub and politically stable nation.
We maintain a BUY calls - on Riverstone and UG Healthcare with TPs of SGD1.18 and SGD0.52." - John Cheong
The beneficiaries will be the investment bankers and perhaps the substantial shareholder that will be selling its stake.
Positive for SGX-listed glovemakers.
This could pan out well for the Singapore-listed glovemakers, as they are trading at a notable discount of around 25% in terms of forward P/E vs the Malaysia-listed ones, due to lack of understanding, having only a small cluster of glove stocks listed here and less news flow.
Malaysia has 7 listed glove stocks vs 2 in Singapore.
Full report here. Courtesy from NextInsight
Private placement only.....I will avoid..bbs can pump up and down as they like...lol
teeth53 ( Date: 17-Mar-2016 07:13) Posted:
|
 Anchor Resources Limited Offer Document.pdf 6.85 MB Anchor Resources Limited Product Highlights Sheet.pdf 0.24 MB |
teeth53 ( Date: 17-Mar-2016 07:08) Posted:
|
Anchor Resources - IPO At S$0.25 Per Placement Share.
A total of 28.8 mil shares on offered, it raises S$7.2m and will list on Catalist board tomorrow.
Anchor Resources Limited is engaged in the business of exploration, mining and production of gold for sale in Malaysia. Headquartered in Malaysia, the Group have concession rights to the Lubuk Mandi Mine and the Bukit Panji Property located in Terengganu, Malaysia...
Attachments:
Pumped up the price of the warrants while the mother shares are sold off. Crap!!
teeth53 ( Date: 28-Jan-2016 16:21) Posted:
|
Wrt to conversion is still far away. $0.350c minus $0.015c.
Mother shr has to be trading at $0.335c to break even.
So where will Secura stand. Oni If BBs is kind enough to pump beyond $0.350 cents. So retailers can let go....please do ur sum n homework.
Mother shr has to be trading at $0.335c to break even.
So where will Secura stand. Oni If BBs is kind enough to pump beyond $0.350 cents. So retailers can let go....please do ur sum n homework.
teeth53 ( Date: 28-Jan-2016 15:47) Posted:
|
Secura one lotter is guarantee one lot. One lotter a real loser. :((
Current mother shr changing@$0.235c n wrt changing@$0.015c
Current mother shr changing@$0.235c n wrt changing@$0.015c
Secura - One mother shr for two free wrt. If they let go now in big volume?.
Still can get back their capital intact...:))
Still can get back their capital intact...:))
teeth53 ( Date: 28-Jan-2016 14:48) Posted:
|
Following is refer to Secura 1st trading day...thot BBs bot at $0.06 c. Is tat true?.
teeth53 ( Date: 28-Jan-2016 14:46) Posted:
|
Look like they 1 2 buy even cheaper...Mother shr $0.225c + wrt shr $0.014c.
Still lossing $0.011c...very second n minute ticking away.
Still lossing $0.011c...very second n minute ticking away.
teeth53 ( Date: 15-Jan-2016 22:27) Posted:
|